Exhibit 10.41
Original Copy USAT/RadiSys Confidential
This Development and Manufacturing Agreement (DMA), is made on the date signed (following section 3.19)
between RadiSys Corporation and
USA Technologies, Inc. 200 Plant Avenue Wayne, PA., 19087-3520
USA
RadiSys Corporation (RadiSys) and USA Technologies, Inc, (USAT) agree to act within the following terms
stated in this DMA, which will remain in effect until either party terminates the DMA as provided herein,
RECITALS
A. USAT desires that RadiSys: (1) in the Development Stage, develop the product described in Appendix I (the
Product) that USAT plans to sell, and (2) after completion of the Development Stage, manufacture and sell the
Product that USAT requires, in the Manufacturing Stage.
B. Both parties intend the development and manufacture of the Product to be an interactive process.
Communication and the free flow of information between the parties will be critical. It is anticipated that frequent
and detailed communication will be required from project kick-off through end of life of the product. The
required communication shall include technical discussions, design decisions, and status reporting. The expected
communication channels include email, telephone, video, fax, and teleconferencing. Unless otherwise tn specified,
no in-person meetings between RadiSys and USAT are required,
C. In addition, both parties anticipate that specifications and schedules will be amended and updated over time.
Thus, the parties intend the DMA to accommodate such changes and agree to make good faith and reasonable
efforts to resolve any disputes that may arise.
AGREEMENT
1.0 DEVELOPMENT STAGE
Section I of the DMA is effective from date of execution through the first delivery of a Production Release
product.
1.1 Product definition
1.1.1 Specifications. The Product is described in the RadiSys Product Proposal, as Appendix 1. This Appendix
defines the base-line specification for
PAGE I
Original Copy USAT/RadiSys Confidential
the P